Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
PROTON MAGNETIC RESONANCE SPECTROSCOPY IN DEMENTIA OF ALZHEIMER TYPE
Home
Publications
PROTON MAGNETIC RESONANCE SPECTROSCOPY IN DEMENTIA OF ALZHEIMER TYPE
PROTON MAGNETIC RESONANCE SPECTROSCOPY IN DEMENTIA OF ALZHEIMER TYPE
Authors:
RH
Reinhard Heun
Reinhard Heun
SS
Sabine Schlegel
Sabine Schlegel
MG
Mechthild Graf-Morgenstern
Mechthild Graf-Morgenstern
JT
Jaroslav Tintera
Jaroslav Tintera
JG
Joachim Gawehn
Joachim Gawehn
PS
Peter Stoeter
Peter Stoeter
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Download PDF
Download
Publisher website
Google Scholar
1 March 1997
journal article
Published by
Wiley
in
International Journal of Geriatric Psychiatry
Vol. 12
(3)
,
349-358
DOI:
10.1002/(sici)1099-1166(199703)12:3<349::aid-gps508>3.0.co;2-s
PMID:
9152720
Abstract
Reduced N‐acetyl aspartate (NAA) and increased myo‐inositol (MI) levels have been reported in patients with dementia of Alzheimer type (DAT) in comparison with controls. We wished to assess the validity of these findings and to evaluate possible correlations of metabolite proportions with cognitive dysfunction in DAT. Twelve patients with DAT and 10 healthy age‐matched controls were included. The severity of dementia was assessed using different scales including the Mini‐Mental State Examination. MRS was performed with a conventional 1.5 Tesla scanner in a single voxel in the centrum semi‐ovale (TE=30 ms or TE=136 ms TR=1500 ms). The evaluation of MRS results was limited by low interrater, intermeasurement (different echo times) and test–retest reliabilities, by a high interindividual variance and by the failure to measure absolute metabolite concentrations. These problems in mind, it was remarkable that previously reported reductions of NAA levels in patients with DAT could be reproduced in the present sample. The proportion of NAA was diminished in demented subjects in comparison with controls (37% vs 44.90%; short TE). A non‐significant trend towards minor reductions of creatine, choline and MI proportions in these subjects might indicate that proportions of other metabolites necessarily increase when NAA is reduced. Cognitive dysfunction of demented subjects was significantly correlated with reductions of NAA, but not with increases of MI. Due to the present technical and methodological problems and to the non‐specificity of findings, proton MRS cannot be applied to support the diagnosis of DAT in a clinical setting. © 1997 by John Wiley & Sons, Ltd.
Keywords
DEMENTIA
ALZHEIMER'S DISEASE
MAGNETIC RESONANCE SPECTROSCOPY
PROTON MAGNETIC RESONANCE SPECTROSCOPY
N‐ACETYL ASPARTATE
MYO‐INOSITOL
CREATINE
CHOLINE
Related articles
Cited
Cited by 37 articles
Scroll to top